DuraGen
Total Payments
$37,587
Transactions
23
Doctors
12
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $37,587 | 23 | 12 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $34,148 | 8 | 90.8% |
| Long term medical supply or device loan | $3,439 | 15 | 9.2% |
Payments by Type
Research
$34,148
8 transactions
General
$3,439
15 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Retrospective, Post-Market Clinical Follow-Up Study to Evaluate the Performance and Safety of Suturable DuraGen | Integra LifeSciences Corporation | $34,148 | 0 |
Top Doctors Receiving Payments for DuraGen
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Portland, OR | $34,148 | 8 |
| , M.D., M.P.H | Emergency Medicine | Encinitas, CA | $458.88 | 3 |
| , M.D | Surgical Critical Care | Boston, MA | $408.24 | 1 |
| , MD | Plastic and Reconstructive Surgery | Maywood, NJ | $329.38 | 1 |
| , M.D | Plastic Surgery | Rochester, NY | $329.38 | 1 |
| , DPM | Foot Surgery | Indianapolis, IN | $329.38 | 1 |
| , MD | Otolaryngology | Boston, MA | $329.38 | 1 |
| , MD | Internal Medicine | Glendale, AZ | $307.80 | 2 |
| , DPM | Podiatrist | Millburn, NJ | $231.95 | 1 |
| , DPM | Podiatrist | Berkeley Heights, NJ | $204.12 | 1 |
| , MD | Hand Surgery | Philadelphia, PA | $204.12 | 1 |
| , DPM | Foot & Ankle Surgery | Lansing, MI | $153.90 | 1 |
| , DPM | Foot & Ankle Surgery | San Diego, CA | $152.96 | 1 |
Ad
Manufacturing Companies
- Integra LifeSciences Corporation $37,587
Product Information
- Type Device
- Total Payments $37,587
- Total Doctors 12
- Transactions 23
About DuraGen
DuraGen is a device associated with $37,587 in payments to 12 healthcare providers, recorded across 23 transactions in the CMS Open Payments database. The primary manufacturer is Integra LifeSciences Corporation.
Payment data is available from 2024 to 2024. In 2024, $37,587 was paid across 23 transactions to 12 doctors.
The most common payment nature for DuraGen is "Unspecified" ($34,148, 90.8% of total).
DuraGen is associated with 1 research study, including "A Multicenter, Retrospective, Post-Market Clinical Follow-Up Study to Evaluate the Performance and Safety of Suturable DuraGen" ($34,148).